AVDL logo

Avadel Pharmaceuticals plc (AVDL) Return On Equity

Annual ROE:

-60.44%+420.91%(+87.44%)
December 31, 2024

Summary

  • As of today (October 8, 2025), AVDL annual return on equity is -60.44%, with the most recent change of +420.91% (+87.44%) on December 31, 2024.
  • During the last 3 years, AVDL annual ROE has risen by +3.86% (+6.00%).
  • AVDL annual ROE is now -153.12% below its all-time high of 113.79%, reached on December 31, 2019.

Performance

AVDL ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLprofitability metrics

Quarterly ROE:

-3.81%+31.76%(+89.29%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL quarterly return on equity is -3.81%, with the most recent change of +31.76% (+89.29%) on June 1, 2025.
  • Over the past year, AVDL quarterly ROE has increased by +104.64% (+96.49%).
  • AVDL quarterly ROE is now -100.50% below its all-time high of 755.56%, reached on March 31, 2023.

Performance

AVDL Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AVDL ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+87.4%+96.5%
3Y3 Years+6.0%+98.0%
5Y5 Years-153.1%-105.8%

AVDL ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+87.5%-100.5%+99.6%
5Y5-Year-153.1%+87.5%-100.5%+99.6%
All-TimeAll-Time-153.1%+94.8%-100.5%+99.9%

AVDL ROE History

DateAnnualQuarterly
Jun 2025
-
-3.81%(+89.3%)
Mar 2025
-
-35.57%(+43.9%)
Dec 2024
-60.44%(+87.4%)
-63.43%(+26.4%)
Sep 2024
-
-86.15%(+20.6%)
Jun 2024
-
-108.45%(+47.3%)
Mar 2024
-
-205.66%(+27.7%)
Dec 2023
-481.35%(+0.0%)
-284.41%(+35.0%)
Sep 2023
-
-437.63%(+58.3%)
Jun 2023
-
-1048.41%(-238.8%)
Mar 2023
-
755.56%(+206.1%)
Dec 2022
-481.49%(-648.8%)
-711.81%(-133.1%)
Sep 2022
-
-305.35%(-58.4%)
Jun 2022
-
-192.79%(-108.3%)
Mar 2022
-
-92.56%(-42.4%)
Dec 2021
-64.30%(-708.9%)
-65.00%(-34.9%)
Sep 2021
-
-48.20%(-32.7%)
Jun 2021
-
-36.32%(-794.6%)
Mar 2021
-
-4.06%(-159.9%)
Dec 2020
10.56%(-90.7%)
6.78%(-71.3%)
Sep 2020
-
23.64%(-64.0%)
Jun 2020
-
65.62%(-67.4%)
Mar 2020
-
201.31%(+26.5%)
Dec 2019
113.79%(+152.7%)
159.13%(+104.8%)
Sep 2019
-
-3322.04%(-685.5%)
Jun 2019
-
-422.91%(-97.7%)
Mar 2019
-
-213.96%(-43.5%)
Dec 2018
-215.72%(-301.7%)
-149.05%(-202.7%)
Sep 2018
-
-49.24%(-1182.3%)
Jun 2018
-
-3.84%(-110.7%)
Mar 2018
-
35.94%(-61.5%)
Dec 2017
106.97%(+244.1%)
93.43%(-28.4%)
Sep 2017
-
130.55%(+75.4%)
Jun 2017
-
74.43%(+514.0%)
Mar 2017
-
-17.98%(+76.7%)
Dec 2016
-74.24%(-183.5%)
-77.12%(-244.5%)
Sep 2016
-
53.36%(+64.6%)
Jun 2016
-
32.42%(-24.8%)
Mar 2016
-
43.09%(-59.4%)
Dec 2015
88.90%(+107.7%)
106.06%(+145.8%)
Sep 2015
-
-231.64%(-76.2%)
Jun 2015
-
-131.49%(-14.3%)
Mar 2015
-
-115.06%(+51.0%)
Dec 2014
-1156.13%(-160.9%)
-234.73%(-27.8%)
Sep 2014
-
-183.65%(+28.4%)
Jun 2014
-
-256.56%(+47.7%)
Mar 2014
-
-490.61%(+63.0%)
Dec 2013
-443.11%(-4037.3%)
-1324.61%(-127.1%)
Sep 2013
-
-583.15%(-152.2%)
Jun 2013
-
-231.20%(-424.6%)
Mar 2013
-
-44.07%(-301.4%)
Dec 2012
-10.71%(+59.7%)
-10.98%(+77.3%)
Sep 2012
-
-48.27%(-132.3%)
Jun 2012
-
-20.78%(-73.5%)
Mar 2012
-
-11.98%(+55.1%)
Dec 2011
-26.55%(-20.1%)
-26.69%(-123.9%)
Sep 2011
-
-11.92%(+55.3%)
Jun 2011
-
-26.67%(+6.6%)
Mar 2011
-
-28.55%(-21.5%)
Dec 2010
-22.11%
-23.49%(+47.0%)
DateAnnualQuarterly
Sep 2010
-
-44.30%(-41.9%)
Jun 2010
-
-31.23%(-44.1%)
Mar 2010
-
-21.67%(-70.6%)
Dec 2009
-24.49%(-4.6%)
-12.70%(+71.2%)
Sep 2009
-
-44.17%(+9.7%)
Jun 2009
-
-48.91%(+12.4%)
Mar 2009
-
-55.83%(+12.0%)
Dec 2008
-23.42%(+60.4%)
-63.44%(-134.1%)
Sep 2008
-
-27.10%(+29.3%)
Jun 2008
-
-38.34%(+28.7%)
Mar 2008
-
-53.79%(+10.4%)
Dec 2007
-59.12%(-34.1%)
-60.06%(-1.9%)
Sep 2007
-
-58.96%(-6.2%)
Jun 2007
-
-55.50%(-21.5%)
Mar 2007
-
-45.69%(-4.3%)
Dec 2006
-44.09%(-63.8%)
-43.79%(-4.9%)
Sep 2006
-
-41.73%(+0.1%)
Jun 2006
-
-41.79%(-9.1%)
Mar 2006
-
-38.32%(-45.6%)
Dec 2005
-26.92%(-324.9%)
-26.32%(-93.7%)
Sep 2005
-
-13.59%(-6008.7%)
Jun 2005
-
0.23%(-97.0%)
Mar 2005
-
7.63%(-36.3%)
Dec 2004
11.97%(+278.7%)
11.98%(+115.9%)
Sep 2004
-
5.55%(+3164.7%)
Jun 2004
-
0.17%(-80.5%)
Mar 2004
-
0.87%(+104.6%)
Dec 2003
-6.70%(-122.1%)
-19.02%(+52.3%)
Sep 2003
-
-39.89%(-234.1%)
Jun 2003
-
-11.94%(-0.4%)
Mar 2003
-
-11.89%(-487.3%)
Dec 2002
30.36%(+197.2%)
3.07%(-37.9%)
Sep 2002
-
4.94%(+115.0%)
Jun 2002
-
-32.95%(-13.3%)
Mar 2002
-
-29.09%(-14.7%)
Dec 2001
-31.25%(+36.2%)
-25.37%(-470.9%)
Sep 2001
-
6.84%(+81.4%)
Jun 2001
-
3.77%(-47.4%)
Mar 2001
-
7.17%(+119.0%)
Dec 2000
-48.96%(+1.8%)
-37.83%(+44.2%)
Sep 2000
-
-67.85%(+24.2%)
Jun 2000
-
-89.53%(+20.1%)
Mar 2000
-
-112.11%(-152.6%)
Dec 1999
-49.86%(-2.3%)
-44.39%(+24.9%)
Sep 1999
-
-59.12%(-7.8%)
Jun 1999
-
-54.82%(-17.3%)
Mar 1999
-
-46.74%(+22.1%)
Dec 1998
-48.76%(-34.1%)
-60.01%(-26.4%)
Sep 1998
-
-47.47%(+10.3%)
Jun 1998
-
-52.92%(+15.4%)
Mar 1998
-
-62.58%(-11.8%)
Dec 1997
-36.36%(-21.7%)
-55.99%(-54.0%)
Sep 1997
-
-36.36%(-21.7%)
Jun 1997
-
-29.87%(+2.8%)
Mar 1997
-
-30.74%(+51.9%)
Dec 1996
-29.87%
-63.89%(-118.1%)
Sep 1996
-
353.33%(+35.9%)
Jun 1996
-
260.00%(+160.0%)
Mar 1996
-
100.00%

FAQ

  • What is Avadel Pharmaceuticals plc annual return on equity?
  • What is the all-time high annual ROE for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual ROE year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly return on equity?
  • What is the all-time high quarterly ROE for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?

What is Avadel Pharmaceuticals plc annual return on equity?

The current annual ROE of AVDL is -60.44%

What is the all-time high annual ROE for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual return on equity is 113.79%

What is Avadel Pharmaceuticals plc annual ROE year-on-year change?

Over the past year, AVDL annual return on equity has changed by +420.91% (+87.44%)

What is Avadel Pharmaceuticals plc quarterly return on equity?

The current quarterly ROE of AVDL is -3.81%

What is the all-time high quarterly ROE for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly return on equity is 755.56%

What is Avadel Pharmaceuticals plc quarterly ROE year-on-year change?

Over the past year, AVDL quarterly return on equity has changed by +104.64% (+96.49%)
On this page